Back to Search
ROBERT MIRABILE, M.D.
M.D.
Specialist
NPI: 1932143492Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD027802E(PA)
Research & Publications (17)
Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
PMID 18806801·Nat Med·2008
7-preclinical
Transcriptional profiling of laser capture microdissected rat arterial elements: fenoldopam-induced vascular toxicity as a model system.
PMID 18467687·Toxicol Pathol·2008
7-preclinical
Evaluation of the cynomolgus monkey stomach: recommendations for standard sampling procedures in nonclinical safety studies.
PMID 18364462·Toxicol Pathol·2008
4-observational
p38 MAPK inhibition reduces aortic ultrasmall superparamagnetic iron oxide uptake in a mouse model of atherosclerosis: MRI assessment.
PMID 18162612·Arterioscler Thromb Vasc Biol·2008
7-preclinical
Novel vascular lesions in mice given a non-peptide vitronectin receptor antagonist.
PMID 18098042·Toxicol Pathol·2007
7-preclinical
Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
PMID 17577100·J Cardiovasc Pharmacol·2007
7-preclinical
Inhibition of ALK5 signaling induces physeal dysplasia in rats.
PMID 17366323·Toxicol Pathol·2007
7-preclinical
Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
PMID 15769460·Cardiovasc Res·2005
7-preclinical
Attitudes in the social context: the impact of social network composition on individual-level attitude strength.
PMID 15598106·J Pers Soc Psychol·2004
8-other
SB-236057: Critical window of sensitivity study and embryopathy of a potent musculoskeletal teratogen.
PMID 15472921·Birth Defects Res A Clin Mol Teratol·2004
7-preclinical
Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys.
PMID 15131011·Carcinogenesis·2004
4-observational
Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.
PMID 14962485·Cardiovasc Res·2004
7-preclinical
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.
PMID 14561850·J Pharmacol Exp Ther·2003
7-preclinical
Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.
PMID 14557369·Circulation·2003
7-preclinical
Cloning, expression, and initial characterization of a novel cytokine-like gene family.
PMID 12160727·Genomics·2002
7-preclinical
Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injury.
PMID 11907152·J Pharmacol Exp Ther·2002
7-preclinical
Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.
PMID 10984495·J Biol Chem·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1050 DEKALB PIKE
BLUE BELL, PA 19422 - Phone
- (610) 272-8821
Quick Facts
- NPI
- 1932143492
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile